Big pharmaceutical companies have begun 2019 with a bang. Blockbuster deals like Bristol Myers Squibb's $74 billion deal for Celgene , Eli Lilly's $8 billion deal for Loxo Oncology, and Takeda Pharmaceutical's $62 billion buyout of Shire Plc have signaled the acquisition appetite in the space is...
NEW YORK (Reuters) - Wall Street languished near the starting gate in mid-afternoon trading on Monday as investor hopes over U.S.-China trade talks were muted by concerns about possible congressional..
Boeing smashed Wall Street expectations Wednesday, Jan. 30. The company is Real Money's stock of the day. The company said earnings for the three months ending in December came in at $5.48 per share, a..
A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and... Reuters India Also reported by •RTE.ie •Reuters •SeekingAlpha